Skip to main content
. 2003 Apr;64(4):248–262. doi: 10.1016/S0011-393X(03)00058-4

Table VII.

Adverse events reported by the study subjects (no. [%] of study subjects) during the 6-week supplementation period.

Treatment Group (n = 11) Placebo Group (n = 11)
Constipation 1 (9.1) 0
Headache 1 (9.1) 0
Indigestion 1 (9.1) 0
Dry mouth 0 1 (9.1)
Irritability 0 1 (9.1)
Nausea 0 1 (9.1)
Total events 3 3